Lys26
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.7
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Lys26  -  H1D (human)

Site Information
PVKKKAKkAGATAGk   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 49333113
Available spectra:  1 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Disease tissue studied:
lung cancer ( 1 , 2 ) , small-cell lung cancer ( 1 , 2 )
Relevant cell line - cell type - tissue:
DMS53 (pulmonary) ( 2 ) , DMS79 (pulmonary) ( 1 ) , lung ( 1 , 2 ) , NCI-H128 (pulmonary) ( 1 ) , NCI-H1417 (pulmonary) ( 1 ) , NCI-H209 (pulmonary) ( 1 ) , NCI-H446 (pulmonary) ( 2 ) , NCI-H524 (pulmonary) ( 1 ) , NCI-H526 (pulmonary) ( 2 ) , NCI-H69 (pulmonary) ( 2 ) , NCI-H82 (pulmonary) ( 2 )

References 

1

Rikova K (2013) CST Curation Set: 20125; Year: 2013; Biosample/Treatment: cell line, H1417, DMS79, H128, H209, H524; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info

2

Rikova K (2013) CST Curation Set: 20126; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info